Skip to content

D&A at other companies

Globus Medical logo
Globus MedicalGMED
$29.53M-55.3%
Belden logo
BeldenBDC
$11.39M-14.2%
ST
Sensata TechnologiesST
$15.7M-23.8%
Zebra Technologies logo
Zebra TechnologiesZBRA
$37M+54.2%
Nordson logo
NordsonNDSN
Celestica logo
CelesticaCLS

Segments

By segment

See full
Medical Solutions$3.66M+16.2%
Automation Enabling Technologies$2.12M-12.0%

Other financials

Income statement

See full
Revenue$257.7M+10.4%
Gross profit$113.6M+8.8%
Operating income$27.5M-15.1%
Net income$21.1M-0.5%
EPS (diluted)$0.51-13.6%

Balance sheet

See full
Cash & equivalents$388.8M+267%
Total debt$291.3M-34.2%
Total equity$1.3B+70.3%
Total assets$1.8B+29.9%

Cash flow

See full
Operating cash flow$51.6M+62.9%
CapEx$4.1M-3.4%
Free cash flow$47.5M+73.2%

Valuation

See full
Market cap$5.53B-8.3%
Enterprise value$5.43B-16.6%
P/E103×+17.5×
P/S5.5×-0.8×

Profitability

See full
Gross margin44.2%-0.5pp
Operating margin8.9%-3.5pp
Net margin5.3%-2.1pp
FCF margin6.8%-8.1pp

Returns & leverage

See full
Return on equity5.2%-4.6pp
Debt / equity0.2×-0.4×
Current ratio3.6×+1.0×

Where this comes from

Reported directly by Novanta in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.

The official record: Novanta’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Novanta's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Novanta's D&A?
Novanta (NOVT) reported D&A of $5.77M in Q1 2026.
How has Novanta's D&A changed year-over-year?
Novanta's D&A increased by 4.0% year-over-year, from $5.55M to $5.77M.
What is the long-term trend for Novanta's D&A?
Over 4 years (2021 to 2025), Novanta's D&A has grown at a 13.5% compound annual growth rate (CAGR), from $16.58M to $27.48M.
What does D&A mean?
Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.